Interv Akut Kardiol. 2014;13(4):208-210

Aspiration trombus and distal protection during primary PCI of degenerated vein graft

Lukáš Rychlovský1, Vojtěch Novotný2, Ivo Varvařovský2
1 Interní oddělení, Svitavská nemocnice, Svitavy
2 Kardiologické centrum Agel, Pardubice

Primary angioplasty (PCI) in old saphenous vein grafts (SVG) is often accompanied with distal embolization leading to worse angiographic

outcome and unfavourable prognosis. Thrombus aspiration and distal protection device, in connection with low pressure stent

implantation, were succesfully used to prevent progression of the acute heart failure during PPCI in the old SVG.

Keywords: old saphenous vein graft, acute myocardial infarction, distal protection

Published: December 1, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Rychlovský L, Novotný V, Varvařovský I. Aspiration trombus and distal protection during primary PCI of degenerated vein graft. Interv Akut Kardiol. 2014;13(4):208-210.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Kohl LP, Garberich RF, Yang H. Outcomes of primary percutaneous coronary intervention in ST-segment elevation myocardial infarction patients with previous coronary bypass surgery. JACC Cardiovsc Interv 2014; 9: 981-987. Go to original source... Go to PubMed...
    2. Welsch RC, Granger CB, Westerhout CM. Prior coronary artery bypass graft patients with ST-segment elevation myocardial infarction treated with percutaneous coronary intervention. JACC Cardiovasc Interv 2010; 3: 343-351. Go to original source... Go to PubMed...
    3. Neuman Y, Pereg D, Boyko V. Primary angioplasty in patients following coronary artery bypass surgery: trends in application and outcome. Results from the acute coronary syndrome Israeli Survey (ACSIS) 2000-2008. Catheter Cardiovasc Interv 2011; 78: 532-536. Go to original source... Go to PubMed...
    4. Gaglia MA, Torguson R, Xue Z. Outcomes of patients with acute myocardial infarction from a saphenous vein graft culprit undergoing percutaneous coronary intervention. Catheter Cardiovasc Interv 2011; 78: 23-29. Go to original source... Go to PubMed...
    5. Brodie BR, Versteeg DS, Brodie MM. Poor long-term patient and graft survival after primary percutaneous coronary intervention for acute myocardial infarction due to saphenous vein graft occlusion. Catheter Cardiovasc Interv 2005; 65: 504-509. Go to original source... Go to PubMed...
    6. Sobieraj DM, White CM, Kluger J. Systematic review: comparative effectiveness of adjunctive devices in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention of native vessels. BMC Cardiovasc Disord 2011; 11: 74. Go to original source... Go to PubMed...
    7. Kelbaek H, Terkelsen CJ, Helqvist S. Randomized comparison of distal protection versus conventional treatment in primary percutaneous coronary intervention: the drug elution and distal protection in ST-elevation myocardial infarction (DEDICATION) trial. J Am Coll Cardiol 2008; 51: 899-905. Go to original source... Go to PubMed...
    8. Lonborg J, Kelbaek H, Helqvist S. The impact of distal embolization and distal protection on long-term outcome in patients with ST elevation myocardial infarction randomized to primary percutaneous coronary intervention - results from a randomized study. Eur Heart Cardiovasc Care 2014; Jul 10. pii: 2048872614543780.
    9. Sardela G, Stio RE. Thrombus aspiration in acute myocardial infarction. Rationale and indication. J Cardiol 2014; 6: 924-928. Go to original source... Go to PubMed...
    10. Windecker S and Task Force on Myocardial Revascularization of the ESC and EACTS. 2014 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J 2014; 35: 2541-2619. Go to original source... Go to PubMed...
    11. Yoon CH, Chung WY, Suh JW. Distal protection device aggravated microvascular obstruction evaluated by cardiac MR after primary percutaneous intervention for ST-elevation myocardial infarction. Int J Cardiol 2013; 167: 2002-2007. Go to original source... Go to PubMed...
    12. Ito N, Nanto S, Doi Y. Distal protection during primary coronary intervention can preserve the index of microcirculatory resistance in patients with acute anterior ST-segment elevation myocardial infarction. Circ J 2011; 75: 94-98. Go to original source... Go to PubMed...
    13. Kelbaek H, Terkelsen CJ, Helqvist S. Randomized comparison of distal protection versus conventional treatment in primary percutaneous coronary intervention: the drug elution and distal protection in ST-elevation myocardial infarction (DEDICATION) trial. J Am Coll Cardiol 2008;51:899-905. Go to original source... Go to PubMed...
    14. Baim DS, Wahr D, George B. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation 2002; 105: 1285-1290. Go to original source...
    15. Anthopoulos P, Alexanian I, Karabela G. Impact on myocardial reperfusion using the M-Guard stent in primary percutaneous coronary intervention for ST-elevation myocardial infarction. Int J Cardiol 2014; 176: 546-547. Go to original source... Go to PubMed...
    16. Schachinger V, Hamm CW, Munzel T. A randomized trial of polytetrafluoroethylene-membrane-covered stents compared with conventional stents in aortocoronary saphenous vein grafts.J Am Coll Cardiol 2003; 42: 1360-1369. Go to original source... Go to PubMed...

    Return to the content


    Interventional Cardiology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.